Answers are grounded in this paper and cite their sources.
Clinical evaluation assesses risk stratification in transcatheter aortic valve replacement patients, highlighting persistent uncertainty regarding atrioventricular block.
There is no clear consensus regarding the optimal risk stratification of high-degree atrioventricular block (HDAVB) after transcatheter aortic valve replacement (TAVR).
No takes yet. Share an insight, caveat, or question.
Raad et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: